semaglutide news october 20 2025 Oral Wegovy approved for obesity management by FDA on December 23, Formulation: High‑dose oral (25 mg daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) What the Obesity Drugmakers Expect

GLP-1 regulates production of those hunger hormones, keeping blood sugar levels lower so that you dont feel those weight-loss-sabotaging hunger pangs

The ENDO 2025 study from the Endocrine Society found something crucial

Lifestyle Changes : Adjustments such as increased rest, modified exercise, and weight management can significantly ease joint stress

Vitamin C also plays an important role in the production and absorption of other vital micronutrients too

The dual mechanism of action of Tirzepatide provides an edge in achieving glycemic targets, with studies indicating superior glycemic control and noteworthy weight reduction benefits for patients